To include your compound in the COVID-19 Resource Center, submit it here.

Araclon to begin Phase II trial of AD vaccine

This month, Araclon Biotech S.L. (Zaragoza, Spain) plans to begin enrollment

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE